Follow
Rory J. McCrimmon
Rory J. McCrimmon
Verified email at dundee.ac.uk - Homepage
Title
Cited by
Cited by
Year
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
21612019
Diabetes and cognitive dysfunction
RJ McCrimmon, CM Ryan, BM Frier
The Lancet, 2012
10142012
Exercise management in type 1 diabetes: a consensus statement
MC Riddell, IW Gallen, CE Smart, CE Taplin, P Adolfsson, AN Lumb, ...
The lancet Diabetes & endocrinology 5 (5), 377-390, 2017
8252017
Frequency of thyroid dysfunction in diabetic patients: value of annual screening
P Perros, RJ McCrimmon, G Shaw, BM Frier
Diabetic medicine 12 (7), 622-627, 1995
6911995
Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the …
SA Amiel, P Aschner, B Childs, P Cryer, B de Galan, SA Heller, BM Frier, ...
Diabetologia, 2016
690*2016
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010
SJ Livingstone, D Levin, HC Looker, RS Lindsay, SH Wild, N Joss, ...
Jama 313 (1), 37-44, 2015
6752015
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 131-138, 2019
5152019
Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance
EC McNay, CT Ong, RJ McCrimmon, J Cresswell, JS Bogan, RS Sherwin
Neurobiology of learning and memory 93 (4), 546-553, 2010
4392010
Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia
Q Tong, CP Ye, RJ McCrimmon, H Dhillon, B Choi, MD Kramer, J Yu, ...
Cell metabolism 5 (5), 383-393, 2007
4072007
Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia
SC Ferguson, A Blane, P Perros, RJ McCrimmon, JJK Best, J Wardlaw, ...
Diabetes 52 (1), 149-156, 2003
3682003
Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management
SA Amiel, P Aschner, B Childs, PE Cryer, BE de Galan, BM Frier, ...
The lancet Diabetes & endocrinology 7 (5), 385-396, 2019
3502019
Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
SJ McGurnaghan, A Weir, J Bishop, S Kennedy, LAK Blackbourn, ...
The lancet Diabetes & endocrinology 9 (2), 82-93, 2021
3152021
Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function
SC Ferguson, A Blane, J Wardlaw, BM Frier, P Perros, RJ McCrimmon, ...
Diabetes Care 28 (6), 1431-1437, 2005
3122005
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised …
P Dandona, C Mathieu, M Phillip, L Hansen, SC Griffen, D Tschöpe, ...
The lancet Diabetes & endocrinology 5 (11), 864-876, 2017
3012017
Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways
L Zhou, GM Sutton, JJ Rochford, RK Semple, DD Lam, LJ Oksanen, ...
Cell metabolism 6 (5), 398-405, 2007
2682007
Hypoglycemia in type 1 diabetes
RJ McCrimmon, RS Sherwin
Diabetes 59 (10), 2333-2339, 2010
2582010
Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein …
PJ Meakin, S Chowdhry, RS Sharma, FB Ashford, SV Walsh, ...
Molecular and cellular biology 34 (17), 3305-3320, 2014
2282014
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study
P Dandona, C Mathieu, M Phillip, L Hansen, D Tschöpe, F Thorén, J Xu, ...
Diabetes Care 41 (12), 2552-2559, 2018
2212018
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b …
I Lingvay, AM Catarig, JP Frias, H Kumar, NL Lausvig, CW le Roux, ...
The Lancet Diabetes & Endocrinology 7 (11), 834-844, 2019
2002019
Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia
RJ McCrimmon, M Shaw, X Fan, H Cheng, Y Ding, MC Vella, L Zhou, ...
Diabetes 57 (2), 444-450, 2008
1972008
The system can't perform the operation now. Try again later.
Articles 1–20